Mice treated with IL-17 did not show obvious signs of inflammation on the fourth day after infection, and mice treated with anti-IL-22 antibody did not show obvious signs of inflammation on the third day after infection, while mice in the PBS injection group began to develop hind limb paralysis on the second day after infection (Figure 3f). The gene discussed is IL17A; the disease is infection.